{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:09Z","timestamp":1759104129727,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"shanghai key laboratory of psychotic disorders","award":["13dz2260500"],"award-info":[{"award-number":["13dz2260500"]}]},{"name":"Shanghai Jiao Tong University School of Medicine","award":["TM201506"],"award-info":[{"award-number":["TM201506"]}]},{"name":"National Major Project for IND","award":["2012ZX09303-003"],"award-info":[{"award-number":["2012ZX09303-003"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.psychres.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T16:23:58Z","timestamp":1500740638000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes"],"prefix":"10.1016","volume":"259","author":[{"given":"Huafang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niufan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2017.07.006_bib1","unstructured":"AstraZeneca, 2013. Seroquel (quetiapine fumarate) \u2013 US prescribing information."},{"key":"10.1016\/j.psychres.2017.07.006_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00023210-200923030-00007","article-title":"Quetiapine extended release: in schizophrenia","volume":"23","author":"Baldwin","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2017.07.006_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1176\/appi.ajp.160.2.356","article-title":"The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia","volume":"160","author":"Carpenter","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/NMD.0000000000000068","article-title":"Medication adherence, knowledge about psychosis, and insight among patients with a schizophrenia-spectrum disorder","volume":"202","author":"Chan","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2017.07.006_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1185\/03007995.2012.762903","article-title":"The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia","volume":"29","author":"Chue","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.psychres.2017.07.006_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0447.2002.02437.x","article-title":"Medication adherence of individuals with a first episode of psychosis","volume":"106","author":"Coldham","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.07.006_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0033291799001476","article-title":"A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia","volume":"30","author":"Copolov","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2017.07.006_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40263-016-0346-3","article-title":"Relationships between functional outcomes and symptomatic improvement in atomoxetine-treated adult patients with attention-deficit\/hyperactivity disorder: post hoc analysis of an integrated database","volume":"30","author":"De Bruyckere","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/2045125312453935","article-title":"Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study","volume":"2","author":"Eriksson","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.07.006_bib12","unstructured":"Guy, W., 1976. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"key":"10.1016\/j.psychres.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple test of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.psychres.2017.07.006_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A stagewise rejective multiple test procedure based on a modified Bonferroni test","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.psychres.2017.07.006_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2753\/IMH0020-7411420103","article-title":"Do low- and middle-income countries learn from the experience of high-income countries?","volume":"42","author":"Horvitz-Lennon","year":"2013","journal-title":"Int. J. Ment. Health"},{"key":"10.1016\/j.psychres.2017.07.006_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4088\/JCP.v68n0603","article-title":"Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Kahn","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/da.20017","article-title":"Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia","volume":"20","author":"Kasper","year":"2004","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0006-3223(99)00321-2","article-title":"The use of placebo control groups in the assessment of psychiatric drugs: an historical context","volume":"47","author":"Leber","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.psychres.2017.07.006_bib21","first-page":"S57","article-title":"Hazards of inference: the active control investigation","volume":"30","author":"Leber","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.psychres.2017.07.006_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/YIC.0b013e32834d9f49","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study","volume":"27","author":"Merideth","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.07.006_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CEOR.S44325","article-title":"The personal, societal, and economic burden of schizophrenia in the people's Republic of China: implications for antipsychotic therapy","volume":"5","author":"Montgomery","year":"2013","journal-title":"Clin. Outcomes Res"},{"key":"10.1016\/j.psychres.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.1997.tb10162.x","article-title":"A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia","volume":"96","author":"Peuskens","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4088\/JCP.v63n1211","article-title":"Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis","volume":"63","author":"Sajatovic","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/11207280-000000000-00000","article-title":"Quetiapine extended release: adjunctive treatment in major depressive disorder","volume":"25","author":"Sanford","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2017.07.006_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.9758\/cpn.2011.9.3.122","article-title":"Factors that influence the prescription of antipsychotics for patients with schizophrenia in china","volume":"9","author":"Si","year":"2011","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.psychres.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.psychres.2017.07.006_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/070674379504000401","article-title":"The ethics of placebo-controlled trials","volume":"40","author":"Streiner","year":"1995","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2009.10.007","article-title":"Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression","volume":"121","author":"Suppes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2017.07.006_bib31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies","volume":"28","author":"Thase","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2017.07.006_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2017.07.006_bib34","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116314809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116314809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:26:02Z","timestamp":1759037162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116314809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"alternative-id":["S0165178116314809"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2017.07.006","relation":{},"ISSN":["0165-1781"],"issn-type":[{"type":"print","value":"0165-1781"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizophrenia and acute episodes","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}